J&J | JNJ - Capital Ordinaire

Prix De L'Action
227.50
Variation Quotidienne
-3.15 -1.37%
Mensuellement
-5.18%
Annuel
47.17%
Q2 Prévisions
222.63




Capital Ordinaire Changement Date
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 23.39B 2025-09
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Bayer EUR 982.42M 0 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Biogen USD 146.7M 200K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
CONMED USD 30.96M 9K 2025-09
Cooper Companies USD 195.1M 3.71M 2025-12
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 0 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Globus Medical USD 135.06M 449K 2025-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merck USD 2.49B 15.79M 2025-09
Merit Medical Systems USD 59.29M 72K 2025-09
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Vertex Pharmaceuticals USD 254M 0 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12
Zoetis USD 424.93M 16.54M 2025-12